Stock ScreenerStock IdeasTop Stocks To Sell NowStocks to Sell Today: Zen Rating of F As Of Friday, September 5, 2025F rated (Strong Sell) stocks have averaged an -8.02% annual decline going back to 2003. Even worse is how bad they do during corrections and bear markets. Own them at your own risk.
Stock ScreenerStock IdeasTop Stocks To Sell Now
Market Cap: $30M - $200B
Zen Rating: F
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INKT | MINK THERAPEUTICS INC | NASDAQ | Biotechnology | F | $62.19M | $13.75 | -2.31% | -$11.06M | -4.71x | -1.10 | United States | |
| VRA | VERA BRADLEY INC | NASDAQ | Footwear & Accessories | F | $60.89M | $2.18 | 3.81% | -$34.47M | -0.70x | 0.84 | United States | |
| KPTI | KARYOPHARM THERAPEUTICS INC | NASDAQ | Biotechnology | F | $58.40M | $6.74 | -4.87% | -$78.44M | -0.46x | -1.44 | United States | |
| MOBX | MOBIX LABS INC | NASDAQ | Semiconductors | F | $58.02M | $1.06 | -1.40% | -$38.06M | -0.94x | 80.31 | United States | |
| DTIL | PRECISION BIOSCIENCES INC | NASDAQ | Biotechnology | F | $55.77M | $5.03 | -0.40% | -$16.57M | -1.95x | 1.52 | United States | |
| INMB | INMUNE BIO INC | NASDAQ | Biotechnology | F | $51.04M | $1.92 | -2.54% | -$55.51M | -0.77x | 0.31 | United States | |
| MDAI | SPECTRAL AI INC | NASDAQ | Medical Devices | F | $48.92M | $1.83 | -2.66% | -$13.23M | -2.73x | -2.75 | United States | |
| DMYY | DMY SQUARED TECHNOLOGY GROUP INC | NYSEMKT | Shell Companies | F | $48.47M | $12.37 | 0.65% | -$6.49M | -7.23x | -1.02 | United States | |
| GUTS | FRACTYL HEALTH INC | NASDAQ | Biotechnology | F | $45.26M | $0.90 | -3.54% | -$97.26M | -0.43x | -4.41 | United States | |
| ZYXI | ZYNEX INC | NASDAQ | Medical Distribution | F | $45.14M | $1.49 | 0.00% | -$16.64M | -1.59x | 67.15 | United States | |
| LNZA | LANZATECH GLOBAL INC | NASDAQ | Waste Management | F | $43.75M | $18.86 | -5.46% | -$129.97M | -0.28x | -5.10 | United States | |
| JSPR | JASPER THERAPEUTICS INC | NASDAQ | Biotechnology | F | $43.72M | $2.69 | -1.10% | -$88.84M | -0.45x | 0.98 | United States | |
| INDO | INDONESIA ENERGY CORP LTD | NYSEMKT | Oil & Gas E&P | F | $40.34M | $2.90 | -0.34% | -$4.81M | -5.27x | 0.21 | Indonesia | |
| TELO | TELOMIR PHARMACEUTICALS INC | NASDAQ | Biotechnology | F | $40.03M | $1.24 | 5.08% | -$16.15M | -2.30x | 0.72 | United States | |
| OTLK | OUTLOOK THERAPEUTICS INC | NASDAQ | Biotechnology | F | $39.44M | $0.89 | -0.22% | -$43.25M | -1.56x | -1.60 | United States | |
| GBIO | GENERATION BIO CO | NASDAQ | Biotechnology | F | $38.93M | $5.78 | -3.34% | -$67.79M | -0.53x | 2.32 | United States | |
| MYO | MYOMO INC | NYSEMKT | Medical Devices | F | $38.18M | $1.01 | -1.94% | -$7.41M | -4.59x | 1.20 | United States | |
| USEG | US ENERGY CORP | NASDAQ | Oil & Gas E&P | F | $38.11M | $1.12 | -3.45% | -$16.76M | -1.38x | 0.82 | United States | |
| TBHC | BRAND HOUSE COLLECTIVE INC | NASDAQ | Home Improvement Retail | F | $34.59M | $1.54 | 3.36% | -$10.70M | -0.94x | -14.90 | United States | |
| ZOOZ | ZOOZ POWER LTD | NASDAQ | Specialty Retail | F | $33.28M | $2.74 | 16.60% | -$12.27M | -2.47x | -45.87 | Israel | |
| VVOS | VIVOS THERAPEUTICS INC | NASDAQ | Medical Devices | F | $33.02M | $4.40 | -2.87% | -$13.55M | -2.62x | 4.68 | United States | |
| MDCX | MEDICUS PHARMA LTD | NASDAQ | Biotechnology | F | $32.60M | $1.83 | -8.04% | -$16.73M | -1.37x | 2.67 | United States | |
| KAPA | KAIROS PHARMA LTD | NYSEMKT | Biotechnology | F | $32.15M | $1.55 | 6.16% | -$4.70M | -4.56x | 0.11 | United States |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.